HEADER APOPTOSIS 07-APR-20 6WGZ TITLE CRYSTAL STRUCTURE OF HYBCL-2-4 WITH HYBAK1 BH3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MALTODEXTRIN-BINDING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BCL-2-LIKE 4; COMPND 7 CHAIN: B; COMPND 8 SYNONYM: BCL-2-LIKE PROTEIN 1; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: BAK; COMPND 12 CHAIN: C; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: DAH37_23060; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HYDRA VULGARIS; SOURCE 9 ORGANISM_COMMON: HYDRA; SOURCE 10 ORGANISM_TAXID: 6087; SOURCE 11 GENE: BCL2L1; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 14 MOL_ID: 3; SOURCE 15 SYNTHETIC: YES; SOURCE 16 ORGANISM_SCIENTIFIC: HYDRA VULGARIS; SOURCE 17 ORGANISM_COMMON: HYDRA; SOURCE 18 ORGANISM_TAXID: 6087 KEYWDS ANTIAPOPTOTIC, COMPLEX WITH BH3 MOTIF, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR M.KVANSAKUL,M.G.HINDS,S.BANJARA REVDAT 2 18-OCT-23 6WGZ 1 REMARK REVDAT 1 21-APR-21 6WGZ 0 JRNL AUTH S.BANJARA,J.D.SA,M.G.HINDS,M.KVANSAKUL JRNL TITL CRYSTAL STRUCTURES OF HYBCL-2-4 WITH HYBAK1 BH3 AND HYBAX JRNL TITL 2 BH3 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.68 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 29009 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 1439 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.6800 - 4.7300 1.00 2983 153 0.1911 0.2249 REMARK 3 2 4.7300 - 3.7600 1.00 2856 137 0.1758 0.1963 REMARK 3 3 3.7600 - 3.2800 0.99 2801 128 0.2109 0.2430 REMARK 3 4 3.2800 - 2.9800 0.99 2758 165 0.2566 0.2757 REMARK 3 5 2.9800 - 2.7700 0.99 2778 146 0.2630 0.3022 REMARK 3 6 2.7700 - 2.6100 0.98 2699 149 0.2751 0.2851 REMARK 3 7 2.6100 - 2.4700 0.99 2727 147 0.2646 0.2912 REMARK 3 8 2.4700 - 2.3700 0.99 2727 141 0.2777 0.2807 REMARK 3 9 2.3700 - 2.2800 0.98 2732 143 0.3006 0.3518 REMARK 3 10 2.2800 - 2.2000 0.91 2509 130 0.3658 0.3643 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.258 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.913 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.33 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4355 REMARK 3 ANGLE : 0.624 5911 REMARK 3 CHIRALITY : 0.038 649 REMARK 3 PLANARITY : 0.003 762 REMARK 3 DIHEDRAL : 19.965 1560 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6WGZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-APR-20. REMARK 100 THE DEPOSITION ID IS D_1000248143. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29115 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 43.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 10.80 REMARK 200 R MERGE (I) : 0.13700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.56000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1PQ1 REMARK 200 REMARK 200 REMARK: PLATE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M MAGNESIUM ACETATE TETRA HYDRATE, REMARK 280 20% PEG 3350, PH 6.8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.12250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.40000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.82500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.40000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.12250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.82500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -54.24500 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -370 REMARK 465 TYR A -199 REMARK 465 GLU A -198 REMARK 465 ASN A -197 REMARK 465 GLY A -196 REMARK 465 SER A 0 REMARK 465 PRO B 41 REMARK 465 LYS B 159 REMARK 465 THR B 160 REMARK 465 LYS B 161 REMARK 465 ASN B 162 REMARK 465 HIS B 163 REMARK 465 HIS B 164 REMARK 465 HIS B 165 REMARK 465 HIS B 166 REMARK 465 HIS B 167 REMARK 465 HIS B 168 REMARK 465 SER C 67 REMARK 465 ASN C 68 REMARK 465 GLY C 69 REMARK 465 GLU C 70 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A-369 CG CD CE NZ REMARK 470 LYS A-364 CG CD CE NZ REMARK 470 LYS A-336 CG CD CE NZ REMARK 470 LYS A-287 CG CD CE NZ REMARK 470 LYS A-243 CG CD CE NZ REMARK 470 LYS A-195 CG CD CE NZ REMARK 470 LYS A-191 CG CD CE NZ REMARK 470 GLU B 35 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 269 O HOH A 283 2.05 REMARK 500 O HOH A 276 O HOH A 286 2.05 REMARK 500 O HOH A 201 O HOH A 283 2.06 REMARK 500 O HOH A 233 O HOH A 283 2.07 REMARK 500 O HOH B 313 O HOH B 328 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 283 O HOH C 107 3555 2.02 REMARK 500 O HOH A 283 O HOH C 112 3555 2.03 REMARK 500 O HOH A 283 O HOH C 102 3555 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A-315 -166.19 -117.89 REMARK 500 LEU A-248 84.49 -153.15 REMARK 500 ALA A-202 -70.12 -87.17 REMARK 500 TYR A -87 -46.44 -131.44 REMARK 500 ASN B 61 51.93 -141.39 REMARK 500 HIS B 113 -64.40 -102.96 REMARK 500 REMARK 500 REMARK: NULL DBREF1 6WGZ A -369 -4 UNP A0A4Z0THX4_ECOLX DBREF2 6WGZ A A0A4Z0THX4 27 392 DBREF 6WGZ B 7 162 UNP A7LM80 A7LM80_HYDVU 7 162 DBREF 6WGZ C 67 92 UNP A1E3K5 A1E3K5_HYDVU 67 92 SEQADV 6WGZ MET A -370 UNP A0A4Z0THX INITIATING METHIONINE SEQADV 6WGZ ASN A -3 UNP A0A4Z0THX EXPRESSION TAG SEQADV 6WGZ SER A -2 UNP A0A4Z0THX EXPRESSION TAG SEQADV 6WGZ SER A -1 UNP A0A4Z0THX EXPRESSION TAG SEQADV 6WGZ SER A 0 UNP A0A4Z0THX EXPRESSION TAG SEQADV 6WGZ HIS B 163 UNP A7LM80 EXPRESSION TAG SEQADV 6WGZ HIS B 164 UNP A7LM80 EXPRESSION TAG SEQADV 6WGZ HIS B 165 UNP A7LM80 EXPRESSION TAG SEQADV 6WGZ HIS B 166 UNP A7LM80 EXPRESSION TAG SEQADV 6WGZ HIS B 167 UNP A7LM80 EXPRESSION TAG SEQADV 6WGZ HIS B 168 UNP A7LM80 EXPRESSION TAG SEQRES 1 A 371 MET LYS ILE GLU GLU GLY LYS LEU VAL ILE TRP ILE ASN SEQRES 2 A 371 GLY ASP LYS GLY TYR ASN GLY LEU ALA GLU VAL GLY LYS SEQRES 3 A 371 LYS PHE GLU LYS ASP THR GLY ILE LYS VAL THR VAL GLU SEQRES 4 A 371 HIS PRO ASP LYS LEU GLU GLU LYS PHE PRO GLN VAL ALA SEQRES 5 A 371 ALA THR GLY ASP GLY PRO ASP ILE ILE PHE TRP ALA HIS SEQRES 6 A 371 ASP ARG PHE GLY GLY TYR ALA GLN SER GLY LEU LEU ALA SEQRES 7 A 371 GLU ILE THR PRO ASP LYS ALA PHE GLN ASP LYS LEU TYR SEQRES 8 A 371 PRO PHE THR TRP ASP ALA VAL ARG TYR ASN GLY LYS LEU SEQRES 9 A 371 ILE ALA TYR PRO ILE ALA VAL GLU ALA LEU SER LEU ILE SEQRES 10 A 371 TYR ASN LYS ASP LEU LEU PRO ASN PRO PRO LYS THR TRP SEQRES 11 A 371 GLU GLU ILE PRO ALA LEU ASP LYS GLU LEU LYS ALA LYS SEQRES 12 A 371 GLY LYS SER ALA LEU MET PHE ASN LEU GLN GLU PRO TYR SEQRES 13 A 371 PHE THR TRP PRO LEU ILE ALA ALA ASP GLY GLY TYR ALA SEQRES 14 A 371 PHE LYS TYR GLU ASN GLY LYS TYR ASP ILE LYS ASP VAL SEQRES 15 A 371 GLY VAL ASP ASN ALA GLY ALA LYS ALA GLY LEU THR PHE SEQRES 16 A 371 LEU VAL ASP LEU ILE LYS ASN LYS HIS MET ASN ALA ASP SEQRES 17 A 371 THR ASP TYR SER ILE ALA GLU ALA ALA PHE ASN LYS GLY SEQRES 18 A 371 GLU THR ALA MET THR ILE ASN GLY PRO TRP ALA TRP SER SEQRES 19 A 371 ASN ILE ASP THR SER LYS VAL ASN TYR GLY VAL THR VAL SEQRES 20 A 371 LEU PRO THR PHE LYS GLY GLN PRO SER LYS PRO PHE VAL SEQRES 21 A 371 GLY VAL LEU SER ALA GLY ILE ASN ALA ALA SER PRO ASN SEQRES 22 A 371 LYS GLU LEU ALA LYS GLU PHE LEU GLU ASN TYR LEU LEU SEQRES 23 A 371 THR ASP GLU GLY LEU GLU ALA VAL ASN LYS ASP LYS PRO SEQRES 24 A 371 LEU GLY ALA VAL ALA LEU LYS SER TYR GLU GLU GLU LEU SEQRES 25 A 371 ALA LYS ASP PRO ARG ILE ALA ALA THR MET GLU ASN ALA SEQRES 26 A 371 GLN LYS GLY GLU ILE MET PRO ASN ILE PRO GLN MET SER SEQRES 27 A 371 ALA PHE TRP TYR ALA VAL ARG THR ALA VAL ILE ASN ALA SEQRES 28 A 371 ALA SER GLY ARG GLN THR VAL ASP GLU ALA LEU LYS ASP SEQRES 29 A 371 ALA GLN THR ASN SER SER SER SEQRES 1 B 162 ALA GLN GLU ASP ASN TYR LYS ARG ILE VAL LYS SER TYR SEQRES 2 B 162 VAL GLY GLU LYS LEU ARG LYS LYS GLY LEU LYS ILE ARG SEQRES 3 B 162 GLY TYR GLU GLY GLU GLU LEU LYS PRO PRO VAL ILE GLU SEQRES 4 B 162 ILE ALA LYS THR LEU GLN ARG VAL GLY ASP GLU LEU GLU SEQRES 5 B 162 SER ALA ASN THR ASP PHE PHE LYS ASN MET CYS ASP GLN SEQRES 6 B 162 LEU GLN ILE THR PRO SER THR ALA TYR PRO THR PHE GLN SEQRES 7 B 162 SER ILE ALA ASP GLU ILE PHE VAL SER GLY LYS ASN TRP SEQRES 8 B 162 GLY ARG VAL VAL ALA PHE LEU THR PHE GLY GLY ASN PHE SEQRES 9 B 162 ALA VAL HIS CYS ALA LEU ARG ALA ASP MET GLY GLU GLU SEQRES 10 B 162 TYR VAL ASP ARG VAL VAL ASN TRP ILE SER LYS TYR MET SEQRES 11 B 162 ALA VAL ASN LEU ASP TYR TRP ILE ASN GLN GLN GLY GLY SEQRES 12 B 162 TRP ASP GLY PHE LEU ILE PHE PHE GLU LYS THR LYS ASN SEQRES 13 B 162 HIS HIS HIS HIS HIS HIS SEQRES 1 C 26 SER ASN GLY GLU THR GLU ASN LEU GLY ARG VAL LEU ALA SEQRES 2 C 26 SER PHE GLY ASP GLU ILE ASN ASP LYS TYR ARG GLN VAL HET GLC D 1 23 HET GLC D 2 21 HET GLC D 3 22 HET ACT B 201 7 HET ACT B 202 7 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM ACT ACETATE ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 4 GLC 3(C6 H12 O6) FORMUL 5 ACT 2(C2 H3 O2 1-) FORMUL 7 HOH *128(H2 O) HELIX 1 AA1 GLY A -354 GLY A -338 1 17 HELIX 2 AA2 LYS A -328 THR A -317 1 12 HELIX 3 AA3 ARG A -304 SER A -297 1 8 HELIX 4 AA4 ASP A -288 ASP A -283 1 6 HELIX 5 AA5 TYR A -280 VAL A -273 1 8 HELIX 6 AA6 THR A -242 GLU A -240 5 3 HELIX 7 AA7 GLU A -239 LYS A -228 1 12 HELIX 8 AA8 GLU A -217 PHE A -214 5 4 HELIX 9 AA9 THR A -213 ASP A -206 1 8 HELIX 10 AB1 ASN A -185 ASN A -169 1 17 HELIX 11 AB2 ASP A -161 LYS A -151 1 11 HELIX 12 AB3 GLY A -142 TRP A -140 5 3 HELIX 13 AB4 ALA A -139 LYS A -131 1 9 HELIX 14 AB5 ASN A -98 TYR A -87 1 12 HELIX 15 AB6 THR A -84 LYS A -73 1 12 HELIX 16 AB7 LEU A -66 ALA A -58 1 9 HELIX 17 AB8 ASP A -56 GLY A -43 1 14 HELIX 18 AB9 GLN A -35 SER A -18 1 18 HELIX 19 AC1 THR A -14 SER A -2 1 13 HELIX 20 AC2 GLN B 8 GLY B 28 1 21 HELIX 21 AC3 VAL B 43 ALA B 60 1 18 HELIX 22 AC4 ASN B 61 ASN B 67 1 7 HELIX 23 AC5 ASN B 67 GLN B 73 1 7 HELIX 24 AC6 THR B 78 VAL B 92 1 15 HELIX 25 AC7 ASN B 96 HIS B 113 1 18 HELIX 26 AC8 CYS B 114 ARG B 117 5 4 HELIX 27 AC9 GLU B 123 LEU B 140 1 18 HELIX 28 AD1 LEU B 140 GLN B 147 1 8 HELIX 29 AD2 GLY B 148 PHE B 157 1 10 HELIX 30 AD3 GLU C 72 ARG C 90 1 19 SHEET 1 AA1 6 LYS A-336 GLU A-332 0 SHEET 2 AA1 6 LYS A-364 TRP A-360 1 N ILE A-361 O GLU A-332 SHEET 3 AA1 6 ILE A-311 ALA A-307 1 O PHE A-309 N TRP A-360 SHEET 4 AA1 6 PHE A-112 ILE A-104 -1 O GLY A-105 N ILE A-310 SHEET 5 AA1 6 TYR A-264 GLU A-259 -1 N GLU A-259 O GLY A-110 SHEET 6 AA1 6 ALA A -69 VAL A -68 -1 O ALA A -69 N VAL A-260 SHEET 1 AA2 5 LYS A-336 GLU A-332 0 SHEET 2 AA2 5 LYS A-364 TRP A-360 1 N ILE A-361 O GLU A-332 SHEET 3 AA2 5 ILE A-311 ALA A-307 1 O PHE A-309 N TRP A-360 SHEET 4 AA2 5 PHE A-112 ILE A-104 -1 O GLY A-105 N ILE A-310 SHEET 5 AA2 5 GLU A -42 ILE A -41 1 O GLU A -42 N VAL A-111 SHEET 1 AA3 2 ARG A-272 TYR A-271 0 SHEET 2 AA3 2 LYS A-268 LEU A-267 -1 O LYS A-268 N TYR A-271 SHEET 1 AA4 4 SER A-225 LEU A-223 0 SHEET 2 AA4 4 THR A-148 ASN A-143 1 O ALA A-147 N SER A-225 SHEET 3 AA4 4 SER A-256 ASN A-252 -1 N ASN A-252 O ALA A-147 SHEET 4 AA4 4 TYR A-128 THR A-125 -1 O THR A-125 N LEU A-255 SHEET 1 AA5 2 TYR A-203 PHE A-201 0 SHEET 2 AA5 2 VAL A-189 GLY A-188 -1 O GLY A-188 N TYR A-203 SSBOND 1 CYS B 69 CYS B 114 1555 1555 2.03 LINK O4 GLC D 1 C1 GLC D 2 1555 1555 1.35 LINK O4 GLC D 2 C1 GLC D 3 1555 1555 1.37 CRYST1 54.245 73.650 140.800 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018435 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013578 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007102 0.00000